Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

A phase 1, single-center, randomized, dose finding study to evaluate the safety, tolerability, and immunogenicity of a prophylactic COVID-19 pDNA vaccine after single ascending doses in healthy adults.

Almansour-Alzamil I
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
data protection law GDPR
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 145913
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.